BPTH - Bio-Path Holdings, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-3713-
Cost of Revenue----
Gross Profit-3713-
Operating Expenses
Research Development4,6035,4805,4743,020
Selling General and Administrative3,3793,5233,0142,465
Non Recurring----
Others----
Total Operating Expenses7,9829,0038,4885,485
Operating Income or Loss-7,982-8,966-8,475-5,485
Income from Continuing Operations
Total Other Income/Expenses Net-6011,9431,72518
Earnings Before Interest and Taxes-7,982-8,966-8,475-5,485
Interest Expense----
Income Before Tax-8,583-7,023-6,750-5,467
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-8,583-7,023-6,750-5,467
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,583-7,023-6,750-5,467
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,583-8,061-6,750-5,467